Show simple item record

dc.contributor.authorJohansson, Edvard
dc.contributor.authorKallionpää, Roope A.
dc.contributor.authorBöckerman, Petri
dc.contributor.authorPeltonen, Sirkku
dc.contributor.authorPeltonen, Juha
dc.date.accessioned2023-02-24T07:32:39Z
dc.date.available2023-02-24T07:32:39Z
dc.date.issued2022
dc.identifier.citationJohansson, E., Kallionpää, R. A., Böckerman, P., Peltonen, S., & Peltonen, J. (2022). The rare disease neurofibromatosis 1 as a source of hereditary economic inequality : evidence from Finland. <i>Genetics in Medicine</i>, <i>24</i>(4), 870-879. <a href="https://doi.org/10.1016/j.gim.2021.11.024" target="_blank">https://doi.org/10.1016/j.gim.2021.11.024</a>
dc.identifier.otherCONVID_103526772
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/85631
dc.description.abstractPurpose This study investigated whether individuals with neurofibromatosis 1 (NF1) fare worse than individuals without NF1 in terms of economic well-being. NF1 is relatively common in the population and provides an informative case of a rare hereditary disease. Methods We examined a subset of 692 individuals with verified NF1 from the Finnish total population-based NF1 cohort and compared that with 7407 control individuals matched for age, sex, and municipality during 1997-2014. Economic well-being was operationalized with annual work earnings and total income, including social income transfers. Results NF1 significantly worsened economic well-being. Low education, increased morbidity, and reduced labor market participation partly explained the effect of NF1. Yet, NF1 was independently associated with lower income even after adjusting for these factors. Furthermore, NF1 had a larger negative effect on income from work than it had on total income, which indicated that the Finnish social security system partly compensated the labor market losses suffered by individuals with NF1. NF1 had a larger impact on economic inequality for men than for women. Conclusion NF1 contributes to economic inequality. A hereditary disease may convey worse economic well-being over several generations.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesGenetics in Medicine
dc.rightsCC BY-NC-ND 4.0
dc.subject.otherneurofibromatosis
dc.subject.otherNordic model
dc.subject.otherrare diseases
dc.subject.othersocial income transfers
dc.subject.otherwages
dc.titleThe rare disease neurofibromatosis 1 as a source of hereditary economic inequality : evidence from Finland
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202302241893
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.contributor.oppiaineEmpirical Microeconomicsfi
dc.contributor.oppiainePäätöksentekoa tukeva taloustiede ja talouden kilpailukyky (painoala)fi
dc.contributor.oppiaineTaloustiedefi
dc.contributor.oppiaineBasic or discovery scholarshipfi
dc.contributor.oppiaineEmpirical Microeconomicsen
dc.contributor.oppiainePolicy-Relevant Economics and Competitiveness of Economy (focus area)en
dc.contributor.oppiaineEconomicsen
dc.contributor.oppiaineBasic or discovery scholarshipen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange870-879
dc.relation.issn1098-3600
dc.relation.numberinseries4
dc.relation.volume24
dc.type.versionacceptedVersion
dc.rights.copyright© 2021 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysoharvinaiset taudit
dc.subject.ysoneurofibromatoosi
dc.subject.ysoperinnölliset taudit
dc.subject.ysotaloudellinen asema
dc.subject.ysoansiotaso
dc.subject.ysotulonsiirrot
dc.subject.ysoeriarvoisuus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p25145
jyx.subject.urihttp://www.yso.fi/onto/yso/p6082
jyx.subject.urihttp://www.yso.fi/onto/yso/p19997
jyx.subject.urihttp://www.yso.fi/onto/yso/p21597
jyx.subject.urihttp://www.yso.fi/onto/yso/p3481
jyx.subject.urihttp://www.yso.fi/onto/yso/p3475
jyx.subject.urihttp://www.yso.fi/onto/yso/p3478
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.relation.doi10.1016/j.gim.2021.11.024
jyx.fundinginformationThe study was funded with grants from the Turku University Hospital and the Cancer Foundation Finland. This work is generated within the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)—Project ID No 739547. ERN GENTURIS is partly cofunded by the European Union within the framework of the Third Health Programme “ERN2016—Framework Partnership Agreement 2017–2021”.
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY-NC-ND 4.0
Except where otherwise noted, this item's license is described as CC BY-NC-ND 4.0